RxDoctor Payments DataLook up a doctor →

Carl Hanke, MD

MOHS-Micrographic Surgery · Indianapolis, INNPI 1295771244

Payments from drug & device makers

$1,426,000in general payments, 2019–2025

Across 472 payments — averaging $3021.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.2M
  • Endo Pharmaceuticals Inc.$78K
  • Biofrontera Bioscience GmbH$55K
  • Sun Pharmaceutical Industries Inc.$25K
  • Sanofi$24K
  • Biofrontera Inc.$21K
  • plus $42K from 35 others
$6,117in research payments, 2019–2025

Across 2 payments — averaging $3058.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$6K
  • Biofrontera Inc.$78

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few mohs-micrographic surgery providers in Indianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,171,038
Medicare patients
1,644
Services billed
4,948

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other mohs-micrographic surgery in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →